NVST Strangle Strategy
NVST (Envista Holdings Corp), in the Healthcare sector, (Medical - Equipment & Services industry), listed on NYSE.
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
NVST (Envista Holdings Corp) trades in the Healthcare sector, specifically Medical - Equipment & Services, with a market capitalization of approximately $3.89B, a trailing P/E of 57.91, a beta of 0.93 versus the broader market, a 52-week range of 16.41-30.42, average daily share volume of 2.7M, a public-listing history dating back to 2019, approximately 12K full-time employees. These structural characteristics shape how NVST stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.93 places NVST roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 57.91 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a strangle on NVST?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current NVST snapshot
As of May 15, 2026, spot at $23.39, ATM IV 43.60%, IV rank 43.57%, expected move 12.50%. The strangle on NVST below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on NVST specifically: NVST IV at 43.60% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 12.50% (roughly $2.92 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NVST expiries trade a higher absolute premium for lower per-day decay. Position sizing on NVST should anchor to the underlying notional of $23.39 per share and to the trader's directional view on NVST stock.
NVST strangle setup
The NVST strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NVST near $23.39, the first option leg uses a $24.56 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NVST chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NVST shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $24.56 | N/A |
| Buy 1 | Put | $22.22 | N/A |
NVST strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
NVST strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on NVST. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on NVST
Strangles on NVST are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the NVST chain.
NVST thesis for this strangle
The market-implied 1-standard-deviation range for NVST extends from approximately $20.47 on the downside to $26.31 on the upside. A NVST long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current NVST IV rank near 43.57% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on NVST should anchor more to the directional view and the expected-move geometry. As a Healthcare name, NVST options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NVST-specific events.
NVST strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NVST positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NVST alongside the broader basket even when NVST-specific fundamentals are unchanged. Always rebuild the position from current NVST chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on NVST?
- A strangle on NVST is the strangle strategy applied to NVST (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With NVST stock trading near $23.39, the strikes shown on this page are snapped to the nearest listed NVST chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are NVST strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the NVST strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 43.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NVST strangle?
- The breakeven for the NVST strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NVST market-implied 1-standard-deviation expected move is approximately 12.50%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on NVST?
- Strangles on NVST are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the NVST chain.
- How does current NVST implied volatility affect this strangle?
- NVST ATM IV is at 43.60% with IV rank near 43.57%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.